The FDA's restrictive approach toward new drugs, supported by Senator Ted Kennedy,comes at the expense of many patients and possiblyKennedy, too.

With the fates of the Food and Drug Administration and the pharmaceutical industry more intertwined than ever, our health depends on regulatory innovation as much as on scientific progress.